Unaudited Regulatory Disclosure – 30 September 2025

Unaudited Interim Financial Statements – 30 June 2025

Unaudited Regulatory Disclosure – 30 June 2025

Unaudited Regulatory Disclosure – 31 March 2025

Unaudited Regulatory Disclosure – 31 December 2024

Directors’ Report and Financial Statements – 31 December 2024

Unaudited Regulatory Disclosure – 30 September 2024

Unaudited Interim Financial Statements – 30 June 2024

Unaudited Regulatory Disclosure – 30 June 2024

HK$235 million Fixed rate Undated Additional Tier 1 Capital Securities_Sep 2024

Unaudited Regulatory Disclosure – 31 March 2024

Unaudited Regulatory Disclosure – 31 December 2023

Directors’ Report and Financial Statements – 31 December 2023

HK$235 million Fixed rate Undated Additional Tier 1 Capital Securities

Unaudited Regulatory Disclosure – 30 September 2023

Unaudited Interim Financial Statements – 30 June 2023

Unaudited Regulatory Disclosure – 30 June 2023

Unaudited Regulatory Disclosure – 31 March 2023

Unaudited Regulatory Disclosure – 31 December 2022

Directors’ Report and Financial Statements – 31 December 2022

Unaudited Regulatory Disclosure – 30 September 2022

Unaudited Interim Financial Statements – 30 June 2022

Unaudited Regulatory Disclosure – 30 June 2022

Unaudited Regulatory Disclosure – 31 March 2022

Directors’ Report and Financial Statements – 31 December 2021

Unaudited Regulatory Disclosure – 31 December 2021

Unaudited Regulatory Disclosure – 30 September 2021

Unaudited Interim Financial Statements – 30 June 2021

Unaudited Regulatory Disclosure – 30 June 2021

Unaudited Regulatory Disclosure – 31 March 2021

Unaudited Regulatory Disclosure – 31 December 2020

Directors’ Report and Financial Statements – 31 December 2020

Unaudited Regulatory Disclosure - 30 September 2020

Unaudited Interim Financial Statements - 30 June 2020

Unaudited Regulatory Disclosure - 30 June 2020

Capital Instruments – Ordinary Share